List of redirects
Jump to navigation
Jump to search
Showing below up to 250 results in range #1 to #250.
- "Himalayan" P waves → Right atrial enlargement
- "Matrix extracellular phosphoglycoprotein" → Matrix extracellular phosphoglycoprotein
- "Nuclear skeleton" → Nucleoskeleton
- "Phosphorus oxoacids" → Phosphorus oxoacids
- "Port-wine" stain → Capillary malformation#Cutaneous and/or mucosal CM (“port-wine” stain)
- "Widget:Bookshelf" → Widget:Bookshelf
- "a" wave → A wave
- "cannon" A → Cannon a waves
- "cold state" → Cool extremities
- "cross-tolerance" → Cross-tolerance
- "fast-slow" AVNRT → Atypical AVNRT
- "locked in" syndrome → Locked-In syndrome
- "scotch-tape" test → Enterobiasis tape test
- "slow-fast" AVNRT → AVNRT Slow/Fast
- "slow-slow" AVNRT → AVNRT Slow/Slow
- "v" wave → V wave
- 'Himalayan' P waves → Right atrial enlargement
- 'lymphangioma circumscriptum' → Lymphatic malformation#Microcystic LM
- (+/-)-beta-Phenylisopropylamine → Adderall
- (-)-Thyroxine, 3,3',5,5'-Tetraiodo-L-thyronine → Levothyroxine
- (Eisenmenger's syndrome → Eisenmenger's syndrome
- (GERD) → Gastroesophageal reflux disease
- (Hb)A1c → Glycosylated hemoglobin
- (MPO) → Myeloperoxidase
- (carboxyethyl)arginine b-lactam-synthase → (carboxyethyl)arginine beta-lactam-synthase
- *K-C® → Kaolin and Pectin (patient information)
- *K-Pek® → Kaolin and Pectin (patient information)
- *Kapectolin® → Kaolin and Pectin (patient information)
- -phob- → Fear of fish
- 1,1,2,2,2-pentafluoroethane → Pentafluoroethane
- 1,2,4-triazole → 1,2,4-Triazole
- 1,2-dichloroethane → 1,2-Dichloroethane
- 1,25(OH)2D → Calcitriol
- 1,25-dihydroxy vitamin D → Calcitriol
- 1,3-BPG → 1,3-Bisphosphoglycerate
- 1,3-Dehydroadamantane → Propellane
- 1,3-bisphosphoglycerate → 1,3-Bisphosphoglycerate
- 1,3-butadiene → 1,3-Butadiene
- 1,3-cyclohexadiene → 1,3-Cyclohexadiene
- 1,3-dipolar cycloaddition → 1,3-Dipolar cycloaddition
- 1,3-β glucan synthase → 1,3-beta-glucan synthase
- 1,4,5-triphosphate → Inositol triphosphate
- 1,4-Naphthoquinone → Naphthoquinone
- 1,4-dioxane → 1,4-Dioxane
- 1,4-naphthoquinone → Naphthoquinone
- 1,4 Butanediol → 1,4-Butanediol
- 1,5-cyclooctadiene → 1,5-Cyclooctadiene
- 1,6-diaminohexane → Hexamethylenediamine
- 1-Butanol → N-Butanol
- 1-Pentanethiol → Stink bomb
- 1-Propanol → Propan-1-ol
- 1-deoxy-D-xylulose 5-phosphate → 1-Deoxy-D-xylulose 5-phosphate
- 1-methyl-4-benzylpiperazine → 1-Methyl-4-benzylpiperazine
- 10-propargyl-10-deazaaminopterin → Pralatrexate
- 10th cranial nerve disorder → Vagus nerve#Effects of vagus nerve lesions
- 11-b-hydroxylase deficiency → 11β-hydroxylase deficiency
- 11-beta HSD1 → 11β-hydroxysteroid dehydrogenase type 1
- 11-beta HSD2 → Corticosteroid 11-beta-dehydrogenase isozyme 2
- 11-beta hydroxysteroid dehydrogenase → 11Beta Hydroxysteroid dehydrogenase
- 11-cis retinal → Retinene
- 11-deoxycorticosterone → Deoxycorticosterone
- 11-hydroxy-THC → 11-Hydroxy-THC
- 11 Deoxycorticosterone → Deoxycorticosterone
- 11 b hydroxylase deficiency → 11β-hydroxylase deficiency
- 11 beta hydroxylase deficiency → 11β-hydroxylase deficiency
- 11 beta hydroxysteroid dehydrogenase type 2 deficiency → Apparent mineralocorticoid excess
- 11 hydroxylase deficiency → 11β-hydroxylase deficiency
- 11b-hydroxylase deficiency → 11β-hydroxylase deficiency
- 11b hydroxylase deficiency → 11β-hydroxylase deficiency
- 11q deletion → Jacobsen syndrome
- 11β-OH CAH → Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
- 11β-hydroxylase → Steroid 11-beta-hydroxylase
- 12-O-tetradecanoylphorbol-13-acetate → 12-O-Tetradecanoylphorbol-13-acetate
- 12-lead ECG → Echocardiography
- 12-lead ECGs → Electrocardiography
- 12-lead electrocardiograms → Electrocardiography
- 12 lead ECG → Electrocardiography
- 12th cranial nerve → Hypoglossal nerve
- 13-cis retinoic acid → Isotretinoin
- 14-3-3 epsilon → YWHAE
- 14α-demethylase → CYP51A1
- 16S rDNA → Ribosomal RNA
- 16s rRNA → Ribosomal RNA
- 17-Deoxycortisol → Corticosterone
- 17-Hydroxyprogesterone caproate → Hydroxyprogesterone caproate
- 17-N-allylamino-17-demethoxygeldanamycin → 17-N-Allylamino-17-demethoxygeldanamycin
- 17- beta-hydroxysteroid dehydrogenase deficiency → Male pseudohermaphroditism
- 17-alpha-hydroxylase deficiency → 17 alpha-hydroxylase deficiency
- 17-alpha-hydroxypregnenolone → 17-Hydroxypregnenolone
- 17-alpha-hydroxyprogesterone → 17-Hydroxyprogesterone
- 17-hydroxypregnenolone → 17-Hydroxypregnenolone
- 17-hydroxyprogesterone → 17-Hydroxyprogesterone
- 17BHSD3 → 17Beta Hydroxysteroid dehydrogenase
- 17OHP → 17-Hydroxyprogesterone
- 17 alpha hydroxylase deficiency → Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency
- 17 beta-hydroxysteroid dehydrogenase deficiency → 17-beta-hydroxysteroid dehydrogenase deficiency
- 17 beta hydroxysteroide dehydrogenase deficiency → Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency
- 17 hydroxylase deficiency → 17 alpha-hydroxylase deficiency
- 17 hydroxyprogesterone → 17-Hydroxyprogesterone
- 17α-Hydroxypregnenolone → 17-Hydroxypregnenolone
- 17α-hydroxylase → CYP17A1
- 18-hydroxylase → Aldosterone synthase
- 18-hydroxylation → Aldosterone synthase
- 18-methoxycoronaridine → 18-Methoxycoronaridine
- 18 Hydroxycorticosterone → 18-Hydroxycorticosterone
- 18 hydroxylase deficiency → 18-Hydroxylase deficiency
- 18p deletion syndrome → De Grouchy Syndrome
- 18q syndrome → De Grouchy Syndrome
- 1H-nuclear magnetic resonance spectroscopic imaging → Magnetic resonance imaging
- 1 E-21 J → Orders of magnitude (energy)#10-21
- 1 E-6 m → 1 micrometre
- 1 E-7 m → 100 nanometres
- 1 E-8 m → 10 nanometres
- 1 E-9 m → 1 nanometre
- 1p36 Deletion Syndrome → 1p36 deletion syndrome
- 1st degree AV block → First degree AV block
- 1st degree av block → First degree AV block
- 1st degree block → First degree AV block
- 1st degree heart block → First degree AV block
- 1st trimester → Pregnancy#First trimester
- 1α-hydroxylase → 25-Hydroxyvitamin D3 1-alpha-hydroxylase
- 2,2,4-trimethylpentane → 2,2,4-Trimethylpentane
- 2,3,7,8-tetrachlorodibenzo-p-dioxin → Polychlorinated dibenzodioxins
- 2,3-Butanedione → Diacetyl
- 2,3-Diethylpyrazine → Alkylpyrazine
- 2,3-Dimethylbutane → Dimethylbutane
- 2,3-Dimethylpyrazine → Alkylpyrazine
- 2,3-bisphosphoglycerate → 2,3-Bisphosphoglycerate
- 2,3-dimercapto-1-propanesulfonic acid → 2,3-Dimercapto-1-propanesulfonic acid
- 2,3-dimercaptosuccinic acid → Dimercaptosuccinic acid
- 2,4,5-T → 2,4,5-Trichlorophenoxyacetic acid
- 2,4,5-trichlorophenoxyacetic acid → 2,4,5-Trichlorophenoxyacetic acid
- 2,4-D → 2,4-Dichlorophenoxyacetic acid
- 2,4-dichlorophenoxyacetic acid → 2,4-Dichlorophenoxyacetic acid
- 2,4-dimethyl-6-tert-butylphenol → 2,4-Dimethyl-6-tert-butylphenol
- 2,4-dinitrophenylhydrazine → 2,4-Dinitrophenylhydrazine
- 2,4-dinitrophenylhydrazone → 2,4-Dinitrophenylhydrazine
- 2,4 Dienoyl CoA reductase → 2,4 Dienoyl-CoA reductase
- 2,5-Dimethylpyrazine → Alkylpyrazine
- 2,5-dimethoxy-4-(n)-propylthiophenethylamine → 2C-T-7
- 2,5-dimethoxy-4-bromoamphetamine → 2,5-Dimethoxy-4-bromoamphetamine
- 2,5-dimethoxy-4-ethylamphetamine → 2,5-Dimethoxy-4-ethylamphetamine
- 2,5-dimethoxy-4-iodoamphetamine → 2,5-Dimethoxy-4-iodoamphetamine
- 2,5-dimethoxy-4-methylamphetamine → 2,5-Dimethoxy-4-methylamphetamine
- 2,5-dimethoxy-4-nitroamphetamine → 2,5-Dimethoxy-4-nitroamphetamine
- 2,5-dimethoxyamphetamine → Dimethoxyamphetamine
- 2,6-Dimethylpyrazine → Alkylpyrazine
- 2,6-di-tert-butylphenol → 2,6-Di-tert-butylphenol
- 2-AG → 2-Arachidonoylglycerol
- 2-Acetyl-3-Ethylpyrazine → Alkylpyrazine
- 2-Butanone → Butanone
- 2-C-methyl-D-erythritol 4-phosphate → 2-C-methylerythritol 4-phosphate
- 2-Chloroethanol → 2-chloroethanol
- 2-D electrophoresis → Two-dimensional gel electrophoresis
- 2-Ethyl-3-Methylpyrazine → Alkylpyrazine
- 2-Hexanone → Silyl enol ether
- 2-Hydroxybutyrate → 2-Hydroxybutyric acid
- 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency → 2-Methylbutyryl-CoA dehydrogenase deficiency
- 2-PAM → Pralidoxime
- 2-Propanol → Isopropyl alcohol
- 2-acetylamino-fluorene → 2-Acetylaminofluorene
- 2-amino-5-phosphonovalerate → APV (NMDAR antagonist)
- 2-aminoisobutyric acid → 2-Aminoisobutyric acid
- 2-aminopurine → 2-Aminopurine
- 2-arachidonoyl glycerol → 2-Arachidonoylglycerol
- 2-arachidonylglycerol → 2-Arachidonoylglycerol
- 2-bromopropane → 2-Bromopropane
- 2-butene → Butene
- 2-hydroxyglutaricaciduria → 2-Hydroxyglutaricaciduria
- 2-iodoxybenzoic acid → 2-Iodoxybenzoic acid
- 2-methoxyestradiol → 2-Methoxyestradiol
- 2-oxoglutarate → Alpha-ketoglutaric acid
- 2-oxoglutarate dehydrogenase → Oxoglutarate dehydrogenase
- 2-phenoxyethanol → Phenoxyethanol
- 2-propylamine → Isopropylamine
- 20/20 → Visual acuity
- 2006 United States E. coli outbreak → 2006 North American E. coli outbreak
- 2019-nCoV → SARS-CoV-2
- 21-hydroxylase → 21-Hydroxylase
- 21-hydroxylase deficient CAH → 21-hydroxylase deficiency
- 21-hydroxylase deficient congenital adrenal hyperplasia → 21-hydroxylase deficiency
- 21 hydroxylase deficiency → 21-hydroxylase deficiency
- 21 hydroxylase deficient congenital adrenal hyperplasia → 21-hydroxylase deficiency
- 22q → 22q11.2 deletion syndrome
- 22q11.2DS → 22q11.2 deletion syndrome
- 22q11 deletion → 22q11.2 deletion syndrome
- 24-Dinitrotoluene → Toluene diisocyanate
- 24-hour ambulatory electrocardiogram → Holter monitor
- 24 h ambulatory ECG → Holter monitor
- 25-hydroxy vitamin D → Calcidiol
- 25-hydroxylase → CYP27A1
- 2CB → 2C-B
- 2CDA → Cladribine (patient information)
- 2CI → 2C-I
- 2D echocardiography → Two dimensional echocardiography
- 2IT-BAD monoclonal antibody 170 → Monoclonal antibodies
- 2b3a blocker → Glycoprotein IIb/IIIa inhibitors
- 2b3a inhibitor → Glycoprotein IIb/IIIa inhibitors
- 2nd degree av block → Second degree AV block
- 2nd degree block → Second degree AV block
- 2nd degree heart block → Second degree AV block
- 2nd metacarpal → Second metacarpal bone
- 2q37 microdeletion syndrome → Albright like syndrome
- 3',5'-cyclic-nucleotide phosphodiesterase → CGMP specific phosphodiesterase type 5
- 3'UTR → Three prime untranslated region
- 3' UTR → Three prime untranslated region
- 3' end → Directionality (molecular biology)
- 3' flanking region → Directionality (molecular biology)#3' end
- 3,4,5-trimethoxyamphetamine → Trimethoxyamphetamine
- 3,4-methylenedioxy-N-ethylamphetamine → MDEA
- 3,4-methylenedioxyamphetamine → 3,4-Methylenedioxyamphetamine
- 3,4-methylenedioxymetamphetamine → 3,4-Methylenedioxyamphetamine
- 3,4-methylenedioxymethamphetamine → Methylenedioxymethamphetamine
- 3-AP → 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
- 3-Methoxy-4,5-methylendioxyamphetamine → MMDA (psychedelic)
- 3-Methylcrotonylglycinuria type 1 → 3-Methylcrotonyl-CoA carboxylase deficiency
- 3-Methylglutaconic aciduria type II → Barth syndrome
- 3-Methylglutaconyl-CoA → 3-Methylglutaconyl CoA
- 3- Methylglutaconic aciduria type 3 → Methylglutaconyl-CoA hydratase
- 3-allylfentanyl → 3-Allylfentanyl
- 3-alpha hydroxysteroid dehydrogenase → Hydroxysteroid dehydrogenase
- 3-aminophenol → Aminophenol
- 3-aminopyridine-2-carboxaldehyde thiosemicarbazone → 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
- 3-center-4-electron bond → Three-center four-electron bond
- 3-dimensional conformal radiation therapy → Radiation therapy
- 3-dimensional radiation therapy → Radiation therapy
- 3-hydroxy 3-methyl glutaryl-coa lyase deficiency → 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
- 3-hydroxyacyl-coa dehydrogenase deficiency → 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
- 3-methoxy-4,5-methylendioxyamphetamine → MMDA (psychedelic)
- 3-methyl crotonyl-coa carboxylase deficiency → 3-Methylcrotonyl-CoA carboxylase deficiency
- 3-methyl glutaconic aciduria → 3-Methylglutaconic aciduria
- 3-methylcrotonyl-CoA carboxylase → Methylcrotonyl-CoA carboxylase
- 3-methylcrotonyl-CoA carboxylase deficiency → Methylcrotonyl-CoA carboxylase
- 3-methylfentanyl → 3-Methylfentanyl
- 3-methylglutaconic aciduria → 3-Methylglutaconic aciduria
- 3-methylglutaconyl-CoA hydratase → Methylglutaconyl-CoA hydratase
- 3-methylthiofentanyl → 3-Methylthiofentanyl
- 3-phosphoglycerate → Glycerate 3-phosphate
- 3-quinuclidinyl benzilate → 3-Quinuclidinyl benzilate
- 3CPO → Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema
- 3MCC deficiency → 3-Methylcrotonyl-CoA carboxylase deficiency
- 3T/2R → Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
- 3T/2R trial → Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
- 3 10 helix → 310 helix
- 3 beta hydroxysteroid dehydrogenase deficiency → Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency
- 3 day measles → Rubella
- 3 day rash → Roseola
- 3 methylglutaconyl coa hydratase deficiency → 3-Methylglutaconic aciduria
- 3a,7a-dihydroxy-5b-cholestanate-CoA ligase → 3alpha,7alpha-dihydroxy-5beta-cholestanate-CoA ligase
- 3rd degree block → Third degree AV block